Contemporary OB/GYN week in review: vulvovaginal candidiasis, monoclonal antibodies, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: vulvovaginal candidiasis, monoclonal antibodies, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, January 29 - Friday, February 2, 2024), and click each link to read and watch anything you may have missed.
1.) Oteseconazole outperforms fluconazole in treating severe vulvovaginal candidiasis
A phase 3 trial demonstrated that oteseconazole (VIVJOA; Mycovia Pharmaceuticals) capsules exhibit improved therapeutic and mycological cure rates to fluconazole for treating severe vulvovaginal candidiasis.
Click here for the full article.
2.) How monoclonal antibodies revolutionize sexual health
Explore the potential of monoclonal antibodies for contraception and sexually transmitted infection prevention, providing a comprehensive review of their safety, efficacy, and pharmacokinetics.
Click here for the full article.
3.) Two-dose HPV vaccination postpartum shows efficacy
A recent study revealed a 2-dose regimen of human papillomavirus vaccination in postpartum individuals is as effective as a 3-dose approach, providing valuable insights into optimizing vaccination strategies against the virus.
Click here for the full article.
4.) The Guardians app shows efficacy for reducing perinatal depression
Preliminary findings suggest The Guardians mobile app, blending gaming and behavioral activation techniques, could be a solution for alleviating perinatal depression among pregnant women.
Click here for the full article.
5.) Dexmedetomidine found effective for reducing postpartum depression risk
A recent study revealed that early postpartum administration of dexmedetomidine significantly reduces the risk of postpartum depression among women with prenatal depression.
EHR-based models show promise in predicting postpartum depression
December 24th 2024Recent research published highlights the potential of electronic health record data to improve postpartum depression diagnosis, offering a step toward better mental health outcomes for birthing parents.
Read More
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Reduced cost-effectiveness reported from HPV vaccination in mid-adults
November 27th 2024A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Read More
